Posted on 05/11/2009 in Medical Company Financials Haemonetics has posted its financial results for the second quarter of fiscal 2010, revealing that its net revenues reached $157 million (95.2 million pounds) - an improvement of eight per cent on the previous three-month period.
Additionally, net income reached $18 million, representing a rise of 22 per cent.
Earnings per share were also 20 per cent, reaching $0.69.
The second quarter closed for the firm with $20 million of debt and $24 million of free cash flow.
Haemonetics' president and chief executive Brian Concannon stated: "Our blood management solutions are taking hold, driving growth in our hospital business, and leave us well positioned to meet the needs of our customers in today's environment of healthcare reform."
In other Haemonetics news, the organisation revealed last month that Dr Mark Popovsky, its vice-president and chief medical officer, was presented with the Emily Cooley Memorial Award and Lectureship by the AABB.
Other news stories from 05/11/2009
Read more in the Zenopa News Archive
How this news is generated
|
